Evidence map›Paper›PMID 17070802›Full record

ArticleExperimental eye research2007

Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.

Mike O Karl, Kim Peterson-Yantorno, Mortimer M Civan

Abstract read
In one paragraph

Article in Experimental eye research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Regulatory Roles of Anoctamin-6 in Human Trabecular Meshwork Cells.Investigative ophthalmology & visual science · 2017
    Article
  2. Review
  3. Review
  4. Article
  5. Novel ocular antihypertensive compounds in clinical trials.Clinical ophthalmology (Auckland, N.Z.) · 2011
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mike O KarlDepartment of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6085, USA.
Kim Peterson-Yantorno
Mortimer M Civan

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Qi N Cui · 1985 to 2026
$19.5M
Aqueous Humor Outflow Control and Intraocular PressureR01EY013624 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CIVAN, MORTIMER MORDECAI · 2001 to 2013
$5.6M
NEI NIH HHS EY013624NEI NIH HHS EY01583NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY013624
6 · The paper itself

Abstract

Activation of A1 and A2A subtype adenosine receptors (AR) likely exert opposing effects on outflow of aqueous humor, and thereby, on intraocular pressure. Selective agonists of adenosine receptor (AR) subtypes have previously been applied to trabecular meshwork (TM) and Schlemm's canal (SC) cells to identify the site(s) of differential purinergic modulation. However, the apparent changes in volume monitored by previously measuring projected cell area might have partially reflected cell contraction and relaxation. In addition, whole-cell current responses of the TM cells previously described were highly variable following application of selective A1, A2A and A3 agonists. The complexity of the electrophysiologic responses may have reflected cell heterogeneity of the populations harvested from collagenase digestion of TM explants. We now report measurements of TM-cell volume using calcein fluorescence quenching, an approach independent of contractile state. Furthermore, we have applied selective AR agonists to a uniform population of human TM cells, the hTM5 cell line. A1, but not A2A or A3, AR agonists triggered TM-cell shrinkage. Both A1 and A2A AR agonists produced reproducible increases in TM-cell whole-cell currents of similar magnitude. The results suggest that previous measurements of explant-derived TM cells may have reflected a range of responses from phenotypically different cell populations, and that the opposing effects of A1 and A2A agonists on outflow resistance are not likely to be mediated by actions on a single population of TM cells. These opposing effects might reflect AR responses by two or more subpopulations of TM cells, by TM and SC cells or by inner-wall SC cells, alone.

Indexed as

Purinergic P1 Receptor AgonistsAdenosine A1 Receptor AgonistsAdenosine A2 Receptor AgonistsAdenosine A3 Receptor AgonistsAqueous HumorCalciumCell SizeDose-Response Relationship, DrugHumansIon TransportPatch-Clamp TechniquesPotassiumReceptor, Adenosine A1Receptor, Adenosine A2AReceptor, Adenosine A3Receptors, Purinergic P1Adenosine A1 Receptor AgonistsAdenosine A2 Receptor AgonistsAdenosine A3 Receptor AgonistsCalciumPotassiumPurinergic P1 Receptor AgonistsReceptor, Adenosine A1Receptor, Adenosine A2AReceptor, Adenosine A3Receptors, Purinergic P1

Identifiers

PMID17070802
PMCPMC1764820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.